Skip to main content
SpringerLink
Log in

Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease

  • Full Papers
  • Published:
Journal of Neural Transmission - Parkinson's Disease and Dementia Section

Summary

Monoamine oxidase type B (MAO-B) and superoxide dismutase (SOD) are two enzyme stystems that are potentially relevant to an oxidative stress model of Parkinson's disease (PD) causation. Activities of MAO-B in platelets (nmol/108 cells/hr) and total SOD in lymphocytes (U/mg protein) were assayed among 28 cases of idiopathic PD and 22 controls. As anticipated, MAO-B was lowest in PD cases on selegiline (L-deprenyl) therapy (mean 1.10). There was a slight deficit of MAO-B among male cases not taking selegiline compared to controls (3.78 vs. 4.15), but the opposite trend was observed for females (6.18 vs. 4.16). SOD was slightly higher in cases (7.40), than controls (6.81). Excess SOD among PD cases was seen irrespective of gender, age, or selegiline treatment, although none of the differences was statistically significant Future research on SOD should take advantage of the availability of assays specific for the cytosolic and mitochondrial forms of the enzyme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams JD, Odunze IN (1991) Oxygen free radicals: their involvement in disease processes. Ann Clin Biochem 27: 161–169

    Google Scholar 

  • Bonucelli U, Piccini P, Del Dotto P, Pacifici GM, Corsini GU, Muratorio A (1990) Platelet monoamine oxidase B activity in Parkinsonian patients. J Neurol Neurosurg Psychiatry 53: 854–855

    Google Scholar 

  • Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Lab Invest 21 [Suppl 97]: 77–89

    Google Scholar 

  • Calne DB, Langston JW (1983) Aetiology of Parkinson's disease. Lancet ii: 1457–1459

    Google Scholar 

  • Carillo M, Kanai S, Kitani K (1991) (-) Deprenyl induces activities of both superoxide dismutase and catalase but not glutathione peroxidase in the striatum of young rats. Life Sci 48: 517–521

    Google Scholar 

  • Ceballos I, Lafon M, Javoy-Agid F, Hirsch E, Nicole A, Sinet PM, Agid Y (1990) Superoxide dismutase in Parkinson's disease. Lancet 335: 1035–1036

    Google Scholar 

  • Checkoway H, Costa LG, Camp J, Coccini T, Daniell WE, Dills R (1992) Peripheral markers of neurochemical function among styrene-exposed workers. Br J Ind Med (in press)

  • Cohen G (1986) Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. In: Yahr MD, Bergmann KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 119–125

    Google Scholar 

  • Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Platelet MAO-B activity and psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand 78: 730–736

    Google Scholar 

  • Golbe LI, Farrell TM, Davis PH (1990) Follow-up study of early life protective and risk factors in Parkinson's disease. Mov Disord 5: 66–70

    Google Scholar 

  • Hamet P, Fraysse T, Franks DL (1978) Cyclic nucleotides and aggregation of platelets of psontaneously hypertensive rats. Circ Res 43: 365–374

    Google Scholar 

  • Hertzman C, Wiens M, Bowering D, Snow B, Calne D (1990) Parkinson's disease: a casecontrol study of occupational and environmental risk factors. Am J Ind Med 17: 349–355

    Google Scholar 

  • Humfrey CDN, Steventon GB, Sturman SG, Waring RH, Griffiths B, Williams AC (1990) Monoamine oxidase substrates in Parkinson's disease. Biochem Pharmacol 40: 2562–2564

    Google Scholar 

  • Johnson JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 1285–1297

    Google Scholar 

  • Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980

    Google Scholar 

  • Langston JW, Irwin I, Langston EB, Forno LS (1984) 1-Methyl-4-phenylpyridinium on (MPP+): identification of metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 48: 87–92

    Google Scholar 

  • Lee DH, Mendoza M, Dvorozniak MT, Chung E, van Woert MH, Yahr MD (1989) Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy. J Neural Transm [P-D Sect] 1: 189–194

    Google Scholar 

  • Lunec J (1990) Free radicals: Their involvement in disease processes. Ann Clin Biochem 27: 173–182

    Google Scholar 

  • Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A (1983) Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry 46: 905–910

    Google Scholar 

  • Maret G, Testa B, Jenner P, EI Tayar N, Carrupt P-A (1990) The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. Drug Metab Rev 22: 291–332

    Google Scholar 

  • Martilla RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321–331

    Google Scholar 

  • McCord JM, Fridovitch I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049–6055

    Google Scholar 

  • Murphy Dl, Wright C, Buschbaum M, Nichols A, Costa JL, Wyatt RJ (1976) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med 16: 254–265

    Google Scholar 

  • Nakano M, Kimura H, Hara M, Kuroiwa M, Kato M, Totsune K, Yoshikawa T (1990) A highly sensitive method for determining both Mn- and Cu−Zn superoxide dismutase activities in tissues and blood cells. Anal Biochem 187: 277–280

    Google Scholar 

  • Ngim C-H, Devathasan G (1989) Epidemiologic study of the association between body 290 H. Checkoway et al.: MAO-B and superoxide dismutase in Parkinson's disease burden mercury level and idiopathic Parkinson's disease. Neuroepidemioly 8: 128–141

    Google Scholar 

  • Ohno H, Yahara O, Ishikawa M, et al (1990) Serum manganese-superoxide dismutase in individuals with various neuromuscular diseases. Free Rad Biol Med 9: 137

    Google Scholar 

  • Olanow CW (1990) Oxidative reactions in Parkinson's disease. Neurology 40 [Suppl 3]: 32–37

    Google Scholar 

  • Riederer P, Konradi C, Youdim MBH (1990) The role of MAO in dopaminergic transmission. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH (eds) Parkinson's disease: anatomy, pathology, and therapy, Raven Press, New York, pp 149–153 (Adv neurol 53)

    Google Scholar 

  • Rosetti ZL, Sotgio A, Sharp DE, Hadjiconstantinou M, Neff NH (1988) 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem Pharmacol 37: 4573–4574

    Google Scholar 

  • Saggu H, Cooksey J, Dexter D, Wells FR, Less A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in Parksinsonian substantia nigra. J Neurochem 53: 692–697

    Google Scholar 

  • Schapira AHV, Cooper M, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823–827

    Google Scholar 

  • Sinha BK, Singh Y, Krishna G (1986) Formation of superoide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P 450 reductase. Biochem Biophys Res Commun 135: 583–588

    Google Scholar 

  • Snyder SH, D'Amato RJ (1986) MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36: 350–358

    Google Scholar 

  • Steventon G, Hunfrey C, Sturman S, Waring RH, Williams AC (1990) Monoamine oxidase B and Parkinson's disease. Lancet 335: 180

    Google Scholar 

  • Sturman SG, Williams AC, Waring RH, Steventon GB (1991) Is monamine oxidase B metabolism of MPTP different in Parkinson's disease? Neurology 41 [Suppl 1]: 175 (Abstract)

    Google Scholar 

  • Tanner CM (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci 12: 49–54

    Google Scholar 

  • Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK (1989) Regional metal concentrations in Parkinson's disease, other chronic neurological disease, and control brains. Can J Neurol Sci 16: 310–314

    Google Scholar 

  • Williams A, Steventon G, Sturman S, Waring R (1991) Xenobiotic enzyme profiles and Parkinson's disease. Neurology 41 [Suppl 2]: 29–32

    Google Scholar 

  • Yong VW, Perry TL (1986) Monoamine oxidase B, smoking and Parkinson's disease. J Neurol Sci 72: 265–272

    Google Scholar 

  • Young WF, Laws ER, Sharbrough FW, Weinshilboum RM (1986) Human monoamine oxidase-lack of brain and platelet correlation. Arch Gen Psychiatry 43: 604–609

    Google Scholar 

  • Zeller EA, Boshes B, Arbit J, Bieber M, Blonsky ER, Dolkart M, Hupiler SV (1976) Molecular biology of neurological and psychiatric disorders. I. Effects of Parkinsonism, age, sex, and L-Dopa on platelet monoamine oxidase. J Neural Transm 39: 63–77

    Google Scholar 

Download references

Author information

Author notes

  1. H. Checkoway

    Present address: Department of Environmental Health, School of Public Health and Community Medicine, University of Washington, 98195, Seattle, WA, U.S.A.

Authors and Affiliations

  1. Department of Environmental Health, School of Public Health and Community Medicine, University of Washington, 98195, Seattle, WA, U.S.A.

    L. G. Costa, J. S. Woods, A. F. Castoldi & B. O. Lund

  2. Department of Medicine, Neurology Division, School of Medicine, University of Washington, 98195, Seattle, WA, U.S.A.

    P. D. Swanson

Authors
  1. H. Checkoway
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. G. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. S. Woods
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. F. Castoldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. O. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. D. Swanson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Checkoway, H., Costa, L.G., Woods, J.S. et al. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. J Neural Transm Gen Sect 4, 283–290 (1992). https://doi.org/10.1007/BF02260077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02260077

Keywords

Search

Navigation